Cenforce 200 - Centurion Laboratories

Sildenafil citrate, developed in 1989 at Pfizer’s UK labs as UK-92,480, was initially aimed at treating angina. It selectively inhibits PDE5, an enzyme that breaks down cGMP, a molecule involved in smooth muscle relaxation. Though it failed as a heart drug, sildenafil unexpectedly improved erectile function during trials. This led to its rebranding as Viagra and FDA approval in 1998. As the first oral treatment for erectile dysfunction, it revolutionized sexual health and remains the gold standard, backed by over 4,500 trial subjects and millions of successful prescriptions.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Cenforce 200 by Centurion Laboratories, consult with your doctor or healthcare professional.